9
Views
2
CrossRef citations to date
0
Altmetric
Perspective

Establishing a fertility preservation database: no time like the present

Pages 213-225 | Published online: 10 Jan 2014

References

  • Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N. Engl. J. Med.360(9), 902–911 (2009).
  • Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat. Rev. Clin. Oncol.8(1), 56–60 (2011).
  • Fallat ME, Hutter J. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics121(5), e1461–e1469 (2008).
  • Fossa S. Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report. J. Natl Cancer Inst. Monogr.34, 77–82 (2005).
  • Loscalzo M, Clark K. Oncofertility fertility preservation for cancer survivors. In: The Psychological Context of Cancer-Related Infertility. Springer Verlag, NY, USA, 138(Part V), 180–190 (2007).
  • Stahl PJ, Stember DS, Hsiao W, Schlegel PN. Indications and strategies for fertility preservation in men. Clin. Obstet. Gynecol.53(4), 815–827 (2010).
  • Lamar CA, DeCherney AH. Fertility preservation: state of the science and future research directions. Fertil. Steril.91(2), 316–319 (2009).
  • Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr. Opin. Obstet. Gynecol.173, 299–308 (2005).
  • Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil. Steril.83(6), 1622–1628 (2005).
  • Stachecki JJ, Cohen J. An overview of oocyte cryopreservation. Reprod. Biomed. Online9, 152–163 (2004).
  • Bernard A, Fuller BJ. Cryopreservation of human oocytes: a review of current problems and perspectives. Hum. Reprod. Update2, 193–207 (1996).
  • Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil. Steril.86, 70–80 (2006).
  • Chen C. Pregnancy after human oocyte cryopreservation. Lancet2, 884–886 (1986).
  • Al-Hasani S, Diedrich K, Van der Ven H, Reinecke A, Hartje M, Krebs D. Cryopreservation of human oocytes. Hum. Reprod.2, 695–700 (1987).
  • Van Uem JFHM, Siebzehnrubl ER, Schuh B, Koch R, Trotnow S, Lang N. Birth after cryopreservation on unfertilized oocytes. Lancet1, 752–753 (1987).
  • Barritt J, Luna M, Duke M et al. Report of four donor–recipient oocyte cryopreservation cycles resulting in high pregnancy and implantation rates. Fertil. Steril.87, S189 (2007).
  • Boldt J, Tidswell N, Sayers A, Kilani R, Cline D. Human oocyte cryopreservation: 5-year experience with a sodium-depleted slow freezing method. Reprod. Biomed. Online13, 96–100 (2006).
  • Jain JK, Paulson RJ. Oocyte cryopreservation. Fertil. Steril.86(Suppl. 3), 1037–1046 (2006).
  • Maltaris T, Weigel M, Mueller A et al. Cancer and fertility preservation: fertility preservation in breast cancer patients. Breast Cancer Res.10(2), 206 (2008).
  • Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A. Birth following vitrification of a small number of human oocytes. Hum. Reprod.14, 3077–3079 (1999).
  • Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod. Biomed. Online18, 769–776 (2009).
  • Chang CC, Shapiro DB, Bernal DP, Wright G, Kort HI, Nagy ZP. Two successful pregnancies obtained following oocyte vitrification and embryo re-vitrification. Reprod. Biomed. Online16, 346–349 (2008).
  • Chen GA, Cai XY, Lian Y et al. Normal birth from cryopreserved embryos after intracytoplasmic sperm injection of frozen semen into vitrified human oocytes. Hum. Fertil.11, 49–51 (2008).
  • Chian RC, Huang JYJ, Gilbert L et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil. Steril.91, 2391–2398 (2009).
  • Cobo A, Romero JLl, Pérez S, de los Santos MJ, Meseguer M, Remohí J. Storage of human oocytes in the vapour phase of nitrogen. Fertil. Steril.94, 1903–1907 (2010).
  • Fadini R, Brambillasca F, Renzini MM et al. Human oocyte cryopreservation: comparison between slow and ultrarapid methods. Reprod. Biomed. Online19, 171–180 (2009).
  • Keskintepe L, Agca Y, Sher G, Keskintepe M, Maassarani G. High survival rate of metaphase II human oocytes after first polar body biopsy and vitrification: determining the effect of previtrification conditions. Fertil. Steril.92, 1706–1715 (2009).
  • Kim TJ, Laufer LR, Hong SW. Vitrification of oocytes produces high pregnancy rates when carried out in fertile women. Fertil. Steril.93, 467–474 (2010).
  • Liow SL, Foong LC, Chen NQ et al. Live birth from vitrified–warmed human oocytes fertilized with frozen–thawed testicular spermatozoa. Reprod. Biomed. Online19, 198–201 (2009).
  • Nagy ZP, Chang CC, Shapiro DB et al. Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking. Fertil. Steril.92, 520–526 (2009).
  • Rienzi L, Romano S, Albricci L et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling–oocyte study. Hum. Reprod.25, 66–73 (2010).
  • Schoolcraft WB, Keller JL, Schlenker T. Excellent embryo quality obtained from vitrified oocytes. Reprod. Biomed. Online19, 820–823 (2009).
  • Sher G, Keskintepe L, Mukaida T et al. Selective vitrification of euploid oocytes markedly improves survival, fertilization and pregnancy-generating potential. Reprod. Biomed. Online17, 524–529 (2008).
  • Smith GD, Serafini P, Fioravanti J et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil. Steril.94, 2088–2095 (2010).
  • Ubaldi F, Anniballo R, Romano S et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum. Reprod.25, 1199–1205 (2010).
  • Rao GD, Chian RC, Son WS, Gilbert L, Tan SL. Fertility preservation in women undergoing cancer treatment. Lancet363(9423), 1829–1830 (2004).
  • Huang JY, Buckett WM, Gilbert L, Tan SL, Chian RC. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol. Oncol.105(2), 542–544 (2007).
  • Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil. Steril.89(3), 567–572 (2008).
  • Elizur SE, Tulandi T, Meterissian S, Huang JY, Levin D, Tan SL. Fertility preservation for young women with rectal cancer – a combined approach from one referral center. J. Gastrointest. Surg.13(6), 1111–1115 (2009).
  • Huang JY, Chian RC, Gilbert L et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients. Am. J. Surg.200(1), 177–183 (2010).
  • Oktay K, Demirtas E, Son WY, Lostritto K, Chian RC, Tan SL. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil. Steril.89(1), 228.e19–22 (2008).
  • Demirtas E, Elizur SE, Holzer H et al. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod. Biomed. Online17(4), 520–523 (2008).
  • Chian RC, Gilbert L, Huang JY et al. Live birth after vitrification of in vitro matured human oocytes. Fertil. Steril.91(2), 372–376 (2009).
  • Sonmezer M, Oktay K. Fertility preservation in female patients. Hum. Reprod. Update10(3), 251–266 (2004).
  • Campos JR, Rosa-e-Silva ACJS. Cryopreservation and fertility: current and prospective possibilities for female cancer patients. ISRN Obstet. Gynecol.2011, 350813 (2011).
  • Roberts TG, Goulart BH, Squitieri L et al. Trends in the risks and benefits to patients with cancer participating in Phase 1 clinical trials. JAMA292(17), 2130–2140 (2004).
  • Donnez J, Dolmans MM. Preservation of fertility in females with haematological malignancy. Br. J. Haematol.154(2), 175–184 (2011).
  • Jain T. Socioeconomic and racial disparities among infertility patients seeking care. Fertil. Steril.85(4), 876–881 (2006).
  • Holoch P, Wald M. Current options for preservation of fertility in the male. Fertil. Steril.96(2), 286–290 (2011).
  • Neal MS, Nagel K, Duckworth J et al. Effectiveness of sperm banking in adolescents and young adults with cancer: a regional experience. Cancer110(5), 1125–1259 (2009).
  • Quinn GP, Vadaparampil ST, McGowan Lowrey K et al. State laws and regulations addressing third-party reimbursement for infertility treatment: implications for cancer survivors. Fertil. Steril.95(1), 72–78 (2011).
  • Basco D, Campo-Engelstein L, Rodriguez S. Insuring against infertility: expanding state infertility mandates to include fertility preservation technology for cancer patients. J. Law Med. Ethics38(4), 832–839 (2010).
  • Quinn GP, Vadaparampil ST, Lee J et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J. Clin. Oncol.27(35), 5952–5957 (2009).
  • Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum. Reprod.19(3), 477–480 (2004).
  • Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J. Clin. Oncol.26(16), 2630–2635 (2008).
  • Köhler TS, Kondapalli LA, Shah A, Chan S, Woodruff TK, Brannigan RE. Results from the Survey for Preservation of Adolescent Reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J. Assist. Reprod. Genet.28(3), 269–277 (2011).
  • Gilbert E, Adams A, Mehanna H, Harrison B, Hartshorne GM. Who should be offered sperm banking for fertility preservation? A survey of UK oncologists and haematologists. Ann. Oncol.22(5), 1209–1214 (2011).
  • Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol.6, 209–218 (2005).
  • Chung K, Irani J, Knee G et al. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur. J. Obstet. Gynecol. Reprod. Biol.113(Suppl. 1), S7–S11 (2004).
  • Lass A, Akagbosu F, Abusheikha N et al. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years experience. Hum. Reprod.13, 3256–3261 (1998).
  • Lee SJ, Schover LR, Partridge AH et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol.24(18), 2917–2931 (2006).
  • Foley SJ, De Winter P, McFarlane JP et al. Storage of sperm and embryos. Cryopreservation of sperm should be offered to men with testicular cancer. BMJ313(7064), 1078 (1996).
  • Schover LR, Brey K, Lichtin A et al. Knowledge and experience regarding cancer, infertility and sperm banking in younger male survivors. J. Clin. Oncol.20, 1880–1889 (2002).
  • Schover LR, Rybicki LA, Martin BA et al. Having children after cancer: a pilot survey of survivors’ attitudes and experiences. Cancer86, 697–709 (1999).
  • Glaser AW, Phelan L, Crawshaw M et al. Fertility preservation in adolescent males with cancer in the United Kingdom: a survey of practice. Arch. Dis. Child.89, 736–737 (2004).
  • Sanger WG, Olson JH, Sherman JK. Semen cryobanking for men with cancer – criteria change. Fertil. Steril.58, 1024–1027 (1992).
  • Agarwal A, Ranganathan P, Kattal N et al. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil. Steril.81, 342–348 (2004).
  • Audrins P, Holden CA, McLachlan RI et al. Semen storage for special purposes at Monash IVF from 1977 to 1997. Fertil. Steril.72, 179–181 (1999).
  • Blackhall FH, Atkinson AD, Maaya MB et al. Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin’s disease. Br. J. Cancer.87, 381–384 (2002).
  • Ezcurra D, Rangnow J, Craig M, Schertz J. The HOPE registry: first US registry for oocyte cryopreservation. Reprod. Biomed. Online17(6), 743–744 (2008).
  • Fujimoto VY, Luke B, Brown MB et al. Racial and ethnic disparities in assisted reproductive technology (ART) outcomes in the United States. Fertil. Steril.93(2), 382–390 (2008).
  • Seifer D, Frazier L, Grainger D. Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil. Steril.90(5), 1701–1710 (2008).
  • Hotaling JM, Davenport MT, Eisenberg ML, VanDenEeden SK, Walsh TJ. Men who seek infertility care may not represent the general US population: data from the National Survey of Family Growth. Urology79(1), 123–127 (2012).
  • von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B. Fertility preservation in women – a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch. Gynecol. Obstet.284(2), 427–435 (2011).
  • Lawrenz B, Jauckus J, Kupka MS, Strowitzki T, von Wolff M. Fertility preservation in >1000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch. Gynecol. Obstet.283(3), 651–656 (2011).
  • Pedro B. Trend of fertility preservation strategies in Europe. Presented at: 2nd International Society for Fertility Preservation World Congress. Miami, FL, USA, 8–10 December 2011.
  • Plotz D. The Genius Factory: The Curious History of the Nobel Prize Sperm Bank. Random House, London, UK (2005).
  • Krychman ML, King T. Pregnancy after breast cancer: a case study resolving the reproductive challenge with a gestational surrogate. Breast J.12(4), 363–365 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.